To summarize, these findings indicate that SIRT6 plays a dualistic role in urinary system cancers, with tumor-suppressive effects in bladder and kidney cancers and tumor-promoting activity in prostate cancer. This evidence concerns the gene SIRT6 and malignant urinary system neoplasm.